RM
EPZM

RP Management’s Epizyme, Inc EPZM Stock Holding History

RP Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,575,450
Closed -$3.79M – 4
2022
Q2 		$3.79M Buy
2,575,450
+27,166
+1% +$20K 1.5% 4
2022
Q1 		$3.82M Buy
2,548,284
+2,150
+0.1% +$3.5K 1.55% 4
2021
Q4 		$6.37M Buy
2,546,134
+14,086
+0.6% +$55.3K 2.66% 5
2021
Q3 		$13M Buy
2,532,048
+4,312
+0.2% +$26.2K 6.05% 3
2021
Q2 		$21M Buy
2,527,736
+16,259
+0.6% +$137K 10.24% 3
2021
Q1 		$21.9M Buy
2,511,477
+2,156
+0.1% +$22.3K 8.21% 3
2020
Q4 		$27.3M Buy
2,509,321
+9,321
+0.4% +$115K 8.36% 3
2020
Q3 		$29.8M Hold
2,500,000
– – 4.47% 4
2020
Q2 		$40.1M Hold
2,500,000
– – 7.76% 4
2020
Q1 		$38.8M Hold
2,500,000
– – 12.04% 4
2019
Q4 		$61.5M Buy
+2,500,000
New +$37.1M 13.9% 4

Other funds holding EPZM

Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

RP Management's EPZM Position: Q3 2022 in Review

RP Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 31,841,394 shares — an estimated $46.8M sold.

RP Management first reported a position in EPZM in Q4 2019 and held it in 11 quarters. The position peaked at $164M in Q4 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

  • RP Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
  • RP Management sold 31,841,394 Epizyme, Inc shares in Q3 2022, an estimated $46.8M.
  • RP Management first reported a position in Epizyme, Inc in Q4 2019 and held it in 11 quarters.
  • RP Management's Epizyme, Inc position peaked at $164M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on RP Management's 13F filing for Q3 2022, filed 14 Nov 2022.